Skip to content

Evaluating the effectiveness of Hammam i Murattib Ustukhudus and Sibr in Parkinsons Disease

Efficacy of Hammam i Murattib and Ustukhudus with Sibr as an Adjuvant in Parkinsons Disease A Randomized Assessor Blinded Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079257
Enrollment
30
Registered
2025-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: Hammam i Murattib and Ustukhudus (Lavandula stoechas L.) with Sibr (aloe barbadensis) along with carbidopa-levodopa (300-1000mg/day).: After identification and authentication of the dru

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients of Idiopathic Parkinson s Disease (PD) with Yahr staging (Hoehn and yahr scale) equal or less than 3. Patients having the age between 30 and 70 years with either gender having initiation of PD symptoms not more than six years. No treatment change within four weeks before the intervention start. Patient who are willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: Patients taking selective serotonin reuptake inhibitors (SSRIs), and monoamine oxidase inhibitors (MAOIs). Patients with severe systemic disease Patients who suffered from any complication of standard treatment of PD, including urticaria, pruritus, nausea, vomiting, vertigo, etc. Pregnant and lactating women. Patients who fail to follow up

Design outcomes

Primary

MeasureTime frame
Unified Parkinson s Disease rating scale (UPDRS) Part I + II + IIITimepoint: At baseline, 12th day, 24th day and 35th day

Secondary

MeasureTime frame
12-Item Short Form Survey (SF-12)Timepoint: At baseline, 12th day, 24th day and 35th day

Countries

India

Contacts

Public ContactDr Abdul Azeez

National Institute of Unani Medicine

aafaris@gmail.com9035417278

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026